Understanding nerve damage from chemotherapy
Part of Brain & nervous system, Cancer, Pain clinical trials.
This study looks at how chemotherapy-related nerve damage affects daily activities like walking and standing. It includes people who currently have or have had nerve-damaging chemotherapy and are experiencing nerve pain or weakness.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have at least moderate nerve damage from chemotherapy (numbness, tingling, pain, or weakness in hands or feet).
- You are currently receiving or have recently finished chemotherapy that can cause nerve damage.
- You can stand and walk on your own.
- You can fill out a simple questionnaire about your symptoms.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a virtual exercise program to help people with nerve pain or numbness after chemotherapy. It is designed for anyone who finished chemo at least 6 months ago and still has symptoms in their hands or feet.
This study tests whether a personalized exercise program at home can help prevent nerve damage (peripheral neuropathy) caused by certain chemotherapy drugs. It is for people with breast, gynecological, or colon cancer starting a new chemotherapy treatment.
This study tests a personalized rehab program using video analysis to help people with chemotherapy-induced nerve damage (numbness, tingling, weakness) improve their walking and daily life.
This study tests if electroacupuncture (a type of acupuncture with mild electric pulses) combined with exercise can help reduce numbness, tingling, or pain caused by certain chemotherapy drugs. If you have nerve symptoms from taxane or platinum chemo and can walk on your own, this may be a good fit.
This study looks at how chemotherapy that can affect nerves (“neurotoxic” chemo) changes nerve function over time. It may help researchers better measure nerve side effects and improve care for people who need these cancer treatments.
This study looks at chemotherapy-related nerve damage (often felt as numbness, tingling, or pain) and why it happens and should matter. You may be eligible if you had a normal nerve check before chemotherapy started, or if your nerve symptoms are stable after finishing treatment.
Hear when a new Chemotherapy Induced Peripheral Neuropathy (CIPN) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.